Literature DB >> 4608255

Lymphoma with hypercalcemia.

I R Walker.   

Abstract

A prospective survey was carried out to determine the incidence of hypercalcemia in hospitalized patients with lymphoma. Serum calcium determinations were carried out during 440 admissions on 152 patients, most of whom had widespread lymphoma. Forty-one of the 152 patients died, all having had calcium levels recorded on that admission. Two of the 152 patients (1.3%) were found to have hypercalcemia. By comparison hypercalcemia occurred in 6 of 34 patients (17.6%) with multiple myeloma.Hypercalcemia is uncommonly associated with lymphoma but may be seen particularly in centres where many patients with this disease are treated. Hypercalcemia readily responds to therapy and is a reversible cause of morbidity, but when associated with lymphoma it usually indicates widespread disease. The mechanism of hypercalcemia is unknown but there is strong evidence for humoral factors that may or may not be related to parathyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4608255      PMCID: PMC1955891     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  14 in total

1.  Hypercalcemia in malignant disease without evidence of bone destruction.

Authors:  A GELLHORN; C H PLIMPTON
Journal:  Am J Med       Date:  1956-11       Impact factor: 4.965

2.  Hypercalcemia in neoplastic disease.

Authors:  W P L MYERS
Journal:  Cancer       Date:  1956 Nov-Dec       Impact factor: 6.860

3.  Hypercalcemia in malignant lymphoma and leukemia.

Authors:  G P Canellos
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

4.  Prostaglandins and the hypercalcemia of cancer.

Authors:  L G Raisz
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

Review 5.  Hypercalcemic crisis in acute leukemia.

Authors:  D S Benvenisti; L M Sherwood; H O Heinemann
Journal:  Am J Med       Date:  1969-06       Impact factor: 4.965

6.  Mithramycin treatment of hypercalcemia.

Authors:  C P Perlia; N J Gubisch; J Wolter; D Edelberg; M M Dederick; S G Taylor
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

7.  Hypercalcemia associated with neoplastic disease.

Authors:  F M Muggia; H O Heinemann
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

8.  Some thoughts on the nature of ectopic parathyroid hormones.

Authors:  B S Roof; B Carpenter; D J Fink; G S Gordan
Journal:  Am J Med       Date:  1971-05       Impact factor: 4.965

9.  Production of parathyroid hormone by nonparthyroid tumors.

Authors:  L M Sherwood; J L O'Riordan; G D Aurbach; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1967-01       Impact factor: 5.958

10.  Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer.

Authors:  B L Riggs; C D Arnaud; J C Reynolds; L H Smith
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

View more
  6 in total

Review 1.  1,25-Dihydroxyvitamin D-related hypercalcemia in lymphoma: two case reports.

Authors:  J P Devogelaer; M Lambert; B Boland; C Godfraind; H Noel; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Hypercalcaemia in Hodgkin's disease without hyperparathyroidism or skeletal metastases.

Authors:  K M Mayne; C Bunch
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

3.  Angioimmunoblastic lymphadenopathy and hypercalcaemia.

Authors:  M J Sworn; R Buchanan; D A McGill
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

4.  Lymphoma and hypercalcemia in a pediatric orthotopic liver transplant patient.

Authors:  P Nakazato; C O Esquivel; A H Urbach; L Makowka; V Scantlebury; R Jaffe; T E Starzl
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

Review 5.  [Hypocalcemia in malignant diseases].

Authors:  E Heidbreder; K Schafferhans; A Heidland
Journal:  Klin Wochenschr       Date:  1983-08-15

6.  Hypercalcaemia in Hodgkin's disease related to prostaglandin synthesis.

Authors:  J B Laforga; J Vierna; F I Aranda
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.